ETO2转录辅因子通过驱动一个依赖MYB/EP300的干性程序来维持急性白血病
Alexandre Fagnan1,2,3, Zakia Aid1,2, Marie Baille1,2
1Gustave Roussy, INSERM U1170 Université Paris-Saclay Villejuif France.
HemaSphere
|June 21, 2024
概括
ETO2蛋白直接激活MYB的转录,促进白血病. 抑制EP300乙转移酶会降低ETO2的活性及其促进白血病的作用,从而提供一种潜在的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- ETO家族的辅因子经常参与急性白血病.
- 确定了ETO2在基因调节中的作用,特别是其抑制活性.
研究的目的:
- 为了表征红血红血病中的ETO2 regulome.
- 为了研究ETO2的转录性调节功能,超越了压制.
- 探索针对ETO2介导途径的治疗潜力.
主要方法:
- 在红血球白血病模型中进行转录和染色质结合分析.
- ETO2耗尽研究. ETO2耗尽研究.
- 与EP300和MYB的同定位研究.
- 使用小分子和PROTACs抑制EP300乙转移酶.
主要成果:
- ETO2直接激活MYB和其他基因的转录.
- 激活ETO2的基因特征与各种急性白血病亚型的更差的预后相关.
- ETO2,EP300和MYB在增强剂中形成了一个前转录激活循环.
- 抑制EP300降低了ETO2蛋白水平,染色体结合和ETO2激活的转录.
结论:
- ETO2积极促进白血病维护计划,部分通过MYB.
- 该程序依赖于像EP300这样的乙转移酶辅因子,以确保ETO2的稳定性和功能.
- 针对EP300为ETO2驱动的白血病提供了潜在的治疗策略.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Maintenance of the ES Cell State
2.2K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


